Join us for the 2026 GRC Immunochemistry and Immunobiology "Immune Circuitry and Molecular Pathways in Tissue Homeostasis, Infection, and Disease" in beautiful Barcelona. June 28 - July 3, 2026. Great lineup of speakers! www.grc.org/immunochemis...

Don't miss the 2026 Global Immunotalks!

📢Want to speak at the #CancerImmuno conference? Good news! The chairs have released additional short talk slots and extended the submission deadline to 26 February 2026! Submit your abstract for a chance to present your work alongside leading researchers in the field. 👉 Register now: bit.ly/3NRB7Iu

📩 Submit the paper link + short statement (≤250 words) to [email protected] by 15 April 2026. The winner will be selected by EJI editors together with @yefis-immunology.bsky.social representatives. #Immunology #ImmunoSky #AcademicSky #EarlyCareerResearchers #ECR @efis-immunology.bsky.social

🏆Nominations are OPEN for the 2026 EJI-EFIS Prize for the ECR Article of the Year! Best paper published in EJI (2025) by an early-career researcher wins €5,000 + travel grant to ECI 2027 (Florence)✈️ 🔗 Details & eligibility: bit.ly/41GeiMi 🫵 Self-nominations encouraged!

Great story from the Nieswandt lab in Science: uncovering a non-classical platelet mechanism that drives inflammation via integrin- and tetraspanin-rich tethers. A fresh angle on thrombo-inflammation. Happy to be part of this work! www.science.org/doi/10.1126/...

1/ New from our lab 🧪 ARTC2 blockade is widely used to protect tissue Tregs — but when is it truly essential, and for which subsets? 2/ In this @eurjimmunol.bsky.social update, we dissect the subset-specific and context-dependent effects of ARTC2 blockade on hepatic Treg recovery.

Thrilled to contribute to this landmark consensus effort led by Dave Masopust and Rafi Ahmed. A major step toward clearer, shared T cell nomenclature for the field. www.nature.com/articles/s41...

Honoured to see our @natimmunol.nature.com study highlighted in a thoughtful @jhepatology.bsky.social commentary on the IL-27/Kupffer cell axis in chronic HBV — a great summary of why tissue immunity matters and of our work. Paper: tinyurl.com/yt652mxa Commentary: tinyurl.com/56pke5x5

New review out! 😊 20 years after it’s discovery, with @iannaconelab.bsky.social we decided to bring together what we currently know about this cytokine and how it shapes CD8 T cell responses. A small contribution to make sense of a field that is moving fast 🌈 @cp-trendsimmuno.bsky.social

New review out in @cp-trendsimmuno.bsky.social! With @valentinavenzin.bsky.social, we revisit IL-27 as a central regulator of CD8⁺ T cell fate — integrating insights from infection, cancer, and autoimmunity, and outlining its therapeutic potential. www.sciencedirect.com/science/arti...

#CancerImmuno speaker list is live!📢 Join us in sunny Lisbon, July 2026. Register now and submit your talk to share your research. Early Bird Deadline: 15 Jan 2026 👉 Click here to register: bit.ly/4qZVqmd #FusionImmunology #FusionCancerResearch

🎤 Our next episode it out! We chat with Professor Matteo Iannacone ( @iannaconelab.bsky.social ) from @@unisr.bsky.socialabout his work understanding the generation of dysfunctional adaptive immune cells in chronic #HepatitisBVirus infection. 🎧 Listen now: https://bit.ly/4o2W8xa

Join us for this exciting meeting! @embo.org Workshop "Pathogen Immunity and Signalling", 8-12 June, 2026, Leiden, The Netherlands meetings.embo.org/event/26-pat...

🎉Kicking off the 50th annual SSI meeting in Stockholm! Huge thanks to @cgerlachlab.bsky.social for the warm welcome and inspiring introduction! @yssi-immunology.bsky.social @yefis-immunology.bsky.social @efis-immunology.bsky.social @swimm-immuno.bsky.social @iannaconelab.bsky.social

🎉 Congratulations to this year's SSI Young Investigator Award winners! Meet the rising stars of Scandinavian #immunology: John, Jonna, Chris, and Asbjørn @yssi-immunology.bsky.social @yefis-immunology.bsky.social @efis-immunology.bsky.social @iannaconelab.bsky.social @romagnanilab.bsky.social

Our review "From Histology to High-Resolution Mapping: The Rise of Spatial Omics in Immunology" is now online! onlinelibrary.wiley.com/doi/10.1002/...

📣 EJI is proud to share that this year’s Nobel Prize winner, Shimon Sakaguchi, published with us on 6 October: bit.ly/46R7n4g We extend our heartfelt congratulations to Shimon for receiving the prize in recognition of his pioneering work on Tregs. #NobelPrize #Immunology #Tregs

🧵 (1/2) Interested in tertiary lymphoid structures (TLSs)? Check out our latest review, where we chart how TLSs form across organs and contexts — from lung to liver, CNS, skin, gut & more — and their dual roles in protection vs. pathology.

Great to have this out, and such a pleasure to work together. @smguillaume.bsky.social @cristianbeccaria.bsky.social @iannaconelab.bsky.social

So happy to share that our review in #ImmunolRev is finally out! 😃 We discuss how the immune system builds specialized TLSs across organs and conditions. Huge thanks to @StephanGuillaume, @iannaconelab.bsky.social & @linterman.bsky.social for this collaboration! dx.doi.org/10.1111/imr.70063

Don't forget to secure your place at our new conference! Cancer Immunology: Across Space & Time 📅Date: 10 Jul - 13 Jul 2026 🌏Location: Lisbon, Portugal 📢Early Bird & Talk Submission: 15th January 2026 Don't miss out, Register now: bit.ly/3IdEwii #CancerImmuno #FusionImmunology #FusionCancerResearch

Excited to present at the next OBS immuno seminar our recent work from the @iannaconelab.bsky.social! Happy to make science open for everyone 🌈💜

@iannaconelab.bsky.social presenting our work at #IUIS @iuis-online.bsky.social in Vienna highlighting the importance of CD4 T cell mediated help in the liver! 🚀 Thanks @immunologypodcast.com for highlighting our story! @cristianbeccaria.bsky.social podcasts.apple.com/us/podcast/t...

🌟Cheers to the #ACTERIA Early Career Awardees! #EFIS is proud to have supported young scientists and hope Vienna inspired you with new connections, and ideas. 🤝Here’s to the next 50 years of advancing science together!💙 @yefis-immunology.bsky.social @eurjimmunol.bsky.social @iannaconelab.bsky.social

Thrilled to share some of the stories we've been working on in our @iannaconelab.bsky.social at #IUIS2025 @iuis-online.bsky.social in Vienna! Excited to chat with so many friends and colleagues from around the world! @davidemarotta.bsky.social @CaitlinAAbbott

Steffen Jung announced Andreas Radbruch as keynote speaker at #IUIS2025, highlighting his strong support for European Immunology and the importance of backing EJI and European research! Andreas presenting his newest EJI article by Schneider-Revueltas et al. onlinelibrary.wiley.com/doi/10.1002/...

EJI & EFIS are proud to announce the brand-new ECR Article of the Year Award 🏆 Presented by EJI’s Editor-in-Chief Matteo Iannacone at #IUIS2025, this prize celebrates outstanding research by early career researchers published in EJI 🎉 Check the eligibility criteria here👇 bit.ly/3Hvn9t5

Thanks for sharing @brendaraud.bsky.social and @immunologypodcast.com!

📢 Call for papers! Our special issue on Autoimmunity & Environmental Factors is open for submission. ✅Guaranteed peer review for all #IUIS2025 participants! Contribute to advancing our understanding of how modifiable factors influence immune tolerance and autoimmunity 👉 bit.ly/3HFEgIA

Editor-in-Chief Nadja Bakocevic presenting at #IUIS2025 Career Fair on the ways @eurjimmunol.bsky.social and @efis-immunology.bsky.social support early career researchers. ✨ Celebrating 50 years of EJI and introducing the brand-new ECR Article of the Year Prize!

🔬 #EFIS will be at the #IUIS2025 exhibition hall! Come say hello, discover our programs, network with fellow immunologists, learn about EJI prizes, and grab some treats✨ 📅 Aug 17–21 | 📍 Booth # 42 #Immunology @eurjimmunol.bsky.social @yefis-immunology.bsky.social

📢 EJI is at #IUIS2025 in Vienna! Come meet us at the EFIS booth #42 😃 We’d love to hear about your science, answer your publishing questions, and connect with the global immunology community 🔬🌍 See you there! 👋 @yefis-immunology.bsky.social @efis-immunology.bsky.social @iuis-online.bsky.social

Do not miss it! 👇

What can I say... my watercolor made it to the cover of the latest issue of @natimmunol.nature.com, together with our paper on IL-27 in chronic hep B 🚀 We really put the cherry on top in the @iannaconelab.bsky.social @cristianbeccaria.bsky.social. 🥹💜 Check it out! www.nature.com/ni/volumes/2...

Venzin and Beccaria et al. demonstrate that pre-activated CD4+ T cells actively license local hepatic APCs and restore antiviral CD8+ T cell function. bit.ly/4kRAbhS  ‪@valentinavenzin.bsky.social‬  @cristianbeccaria.bsky.social‬  ‪@iannaconelab.bsky.social‬

Drs. @valentinavenzin.bsky.social, @cristianbeccaria.bsky.social, and the @iannaconelab.bsky.social identified the molecular and cellular mechanisms by which CD4⁺ #Tcells can restore antiviral CD8⁺ T cell function in the #liver. @natimmunol.nature.com: go.nature.com/3Ggjajr 🎧: bit.ly/3GP9NaK

Thank you @brendaraud.bsky.social and @drsifujg.bsky.social for highlighting our recent @natimmunol.nature.com (25:40) www.immunologypodcast.com/ep-109-phago...

If you’re too busy to read the paper, here’s the Research Briefing in Nature Immunology 🌈 a quick dive into how CD4⁺ T cells and IL-27 revive CD8⁺ T cells right in the liver! @natimmunol.nature.com @iannaconelab.bsky.social www.nature.com/articles/s41...

Happy to share our latest review "Targeting HBV with RNA interference: Paths to cure"| Science Translational Medicine www.science.org/doi/10.1126/... written together with @cristianbeccaria.bsky.social, Lena Allweiss, Julie Lucifora, John Tavis, Adam Gehring and Maura Dandri

1/ 🚨 Hot off the press in Nature Immunology: CD4⁺ T cells can license Kupffer cells to rescue dysfunctional CD8⁺ T cells in the liver. Hepatitis B virus (HBV) infection is just the proving ground—this is a paradigm shift in tissue immunity. www.nature.com/articles/s41... 🧵(1/11)

Issue 9: Nautilus-like HflK/C assembly controls FtsH proteolysis Viral miRNA double-agent for infecting both animals & plants S-palmitoylation modulates ATG2-dependent lipid transport during autophagy and more! Cover by Mirela Kuka, @iannaconelab.bsky.social et al www.embopress.org/toc/14602075...

"Like a seasoned explorer visiting different regions around the globe, immune cells travel within and between various niches, quickly adapting to local microenvironments." @iannaconelab.bsky.social et al @embojournal.org #Immunology www.embopress.org/doi/full/10....

📣Don't miss out EJI’s comprehensive collection on DCs, featuring Guidelines, cutting-edge research, reviews and more. Explore the full collection bit.ly/4cWkWSP, edited by Björn Clausen and Diana Dudziak @efis-immunology.bsky.social @dgfi-org.bsky.social @dgfi-yi.bsky.social

T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses www.embopress.org/doi/full/10.... @iannaconelab.bsky.social

T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses Mirela Kuka, @iannaconelab.bsky.social and colleagues www.embopress.org/doi/full/10....

💡Exciting news! Our latest study, in collaboration with Prof. Mirela Kuka’s lab, is out now—uncovering how T cell–derived IFN-γ can suppress T follicular helper (TFH) cells and limit antibody responses. 🚀🧵(1/10) www.embopress.org/doi/full/10....

📢Great news for authors: EJI introduces a NEW peer review policy! 📝Manuscripts that have undergone peer review at other journals but weren’t selected can now benefit from a faster, more efficient path to publication. 🔄 Learn more about our Seamless Transfer Policy here: bit.ly/4inhy5j

🚨 New EJI-EFIS Prize for ECRs! 🚨 🏆 €5,000 award for the best research article in EJI by an Early Career Researcher! 🎤 Winner presents at ECI + receives an EFIS–EJI travel grant! 🔗 Apply now: onlinelibrary.wiley.com/page/journal... #ECR #Immunology #EJI #EFIS #ScienceFunding

This will kill science in the US. This is how China wins. Why is this not on the news? Why are people not more upset about this? grants.nih.gov/grants/guide...